Selectivity in DNA Alkylation
Chem. Res. Toxicol., Vol. 9, No. 1, 1996 347
methyl-3-(N-methylcarbamoyl)triazene (25). In addition,
the acyl group also appears to influence DNA alkylation
by a more subtle mechanism, which is as yet undefined.
In any case, the modulation of alkylation by the presence
of specific groups in the acyl position of the triazene has
important implications in the design of new, more potent
chemotherapeutic alkylating agents.
experiment, increased deacylation of CMA (pathway B,
Figure 1) would be necessary to account for this ad-
ditional methylation. Deacylation of CMA would produce
2-(chloroethyl)-3-methyltriazene as the first product.
This, in turn, has been shown preferentially to give the
methanediazonium ion. In order to further investigate
the increased production of 7-methylguanine from CMA,
we attempted to trap the methanediazonium ion as
methanol by incubation of this triazene at 37 °C in a
sealed ampule in buffer, both with and without DNA
present. The results from the NMR spectrometry showed
some (1.5%) methanol in reaction mixtures without DNA
and no methanol when DNA was present, presumably
because the methanediazonium ion was scavenged by the
DNA. No more than a trace of methanol could be found
in a similar experiment from CMC. Thus it appears that
CMA gives a higher yield of the methanediazonium ion
than does CMC. While this yield is small, the high
alkylation efficiency of this species accounts for what
might otherwise seen as unusually low 7-HOETG +
7-ClEtG/7MeG ratio for CMA. We further showed that
the presence of different DNA polymers had no effect on
the rate of triazene decomposition, as compared with the
decomposition of the same triazenes in buffer alone.
However, the presence of the polymer did not increase
the rate.
Ack n ow led gm en t. This research was sponsored by
the National Cancer Institute, DHHS, under Contract
NO1-CO-46000 with ABL. R.H.S. was supported in part
by the National Science Foundation (CHE-9215925). The
authors wish to thank Mr. J ohn Klose for the NMR
spectral determinations and Dr. Grzegorz Czerwinski for
his assistance in the interpretation of the NMR data. The
contents of this publication do not necessarily reflect the
views or policies of the Department of Health and Human
Services, nor does mention of trade names, commercial
products, or organizations imply endorsement by the U.S.
Government.
Refer en ces
(1) Smith, R. H., J r., Scudiero, D. A., and Michejda, C. J . (1990) 1,3-
Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating
agents. J . Med. Chem. 33, 2579-2583.
(2) Kroeger-Koepke, M. B., Michejda, C. J ., and Smith, R. H., J r.
(1992) Alkylation of DNA by 1,3-dialkyl-3-acyltriazenes: correla-
tion of biological activity with chemical behavior. Chem. Res.
Toxicol. 5, 541-547.
One of the interesting, but still unexplained, findings
of the aforementioned alkylation study using the pBR322
fragment (17) was that the nonalkylating portion of a
triazene could influence the ultimate alkylation spec-
trum. In that study, two different (chloroethyl)triazenes
produced different patterns of alkylation, suggesting that
they did not act through a common intermediate (chlo-
roethyl diazohydroxide), as had been previously postu-
lated was the case in the alkylation of DNA by the
(chloroethyl)nitrosoureas (20-24). In our study we have
observed that the ratio of product from CMC to CMA for
any given sequence paralleled the ratio (13) of the rate
of decomposition of the two compounds, suggesting the
same decomposition pathway was operative for both
compounds. This is not the case, however, for the
(hydroxyethyl)triazenes. HMA alkylated the 7-position
of guanine from 0.5 to 2.3 times as much as did HMC,
depending on the sequence. HMA, however, decomposes
at a rate which is 0.2 times that of HMC. Moreover, in
all of the sequences examined except calf thymus DNA,
the amount of methylation from HMA vs HMC appeared
to be elevated at the expense of hydroxyethylation (see
ratios in Table 3). This correlates with the small amount
of methanol detected from HMA, but not HMC, in the
NMR experiments. The fact that HMA also showed this
increased amount of methylation means that the pres-
ence of the acetyl group alone may possibly be a sufficient
condition for deacylation to occur. However, the exact
reason(s) for an acetyl vs a carbethoxy acyl group on the
triazene affecting the balance of decomposition via dif-
ferent pathways awaits further experimentation.
(3) Oakberg, E. F., and Crosthwait, C. D. (1993) The effect of ethyl-,
methyl-, and hydroxyethyl-nitrosoureas on the mouse testis.
Mutat. Res. 108, 337-344.
(4) Pelfene, A., Mirvish, S. S., and Gold, B. (1976) Brief communica-
tion: induction of malignant bone tumors in rats by 1-(2-
hydroxyethyl)-1-nitrosourea. J . Natl. Cancer Inst. 56, 445-446.
(5) Kohn, K. W. (1977) Interstrand cross-linking of DNA by 1,3-bis-
(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitro-
soureas. Cancer Res. 37, 1450-1454.
(6) Lown, J . W., and Chauhan, S. M. S. (1981) Mechanism of action
of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of
postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in
the decomposition of 1,3-bis(2-chloroethyl)-3-(4′-trans-methylcy-
clohexyl)-1-nitrosourea. J . Med. Chem. 24, 270-279.
(7) Tong, W. P., Kirk, M. C., and Ludlum, D. B. (1982) Formation of
the cross-link, 1-[N3-deoxyguanosinyl]-ethane, in DNA treated
with N,N′-bis-(2-chloroethyl)-N-nitrosourea (BCNU). Cancer Res.
42, 3102-3105.
(8) Smith, R. H., J r., Mehl, A. F., Hicks, A., Denlinger, C. L., Kratz,
L., Andrews, A. W., and Michejda, C. J . (1986) 1,3-Dimethyl-
3-acyltriazenes: synthesis and chemistry of a novel class of
biological methylating agents. J . Org. Chem. 51, 3751-3757.
(9) Smith, R. H., J r., Mehl, A. F., Shantz, D. L., Chmurny, G. N.,
and Michejda, C. J . (1988) Novel cross-linking agents, 1-(2-
chloroethyl)-3-methyl-3-acyltriazenes. J . Org. Chem. 53, 1467-
1471.
(10) Koepke, S. R., Kroeger-Koepke, M. B., Bosan, W., Thomas, B. J .,
Alvord, W. G., and Michejda, C. J . (1988) Alkylation of DNA in
rats by N-nitrosomethyl-2-(hydroxyethyl) amine: dose response
and persistence of the alkylated lesions in vivo. Cancer Res. 48,
1537-1542.
(11) Smith, R. H., J r., Wladkowski, B. D., Herling, J . A., Pfaltzgraff,
T. D., Pruski, B., Klose, J ., and Michejda, C. J . (1992) 1,3-
Dialkyl-3-acyltriazenes: Products and rates of decomposition in
acidic and neutral aqueous solutions. J . Org. Chem. 57, 654-
661.
(12) Briscoe, W. T., Anderson, S. P., and May, H. E. (1990) Base
sequence specificity of three 2-chloroethylnitrosoureas. Biochem.
Pharmacol. 40, 1201-1209.
(13) Gibson, N. W., Hartley, J . A., Strong, J . M., and Kohn, K. W.
(1986) 2-Chloroethyl(methylsulfonyl)methanesulfonate (NSC-
338947), a more selective DNA alkylating agent than the chlo-
roethylnitrosoureas. Cancer Res. 46, 553-557.
DNA modifications by acyltriazenes are subject to
multiple factors. One of these is the structure of the acyl
group, which appears to offer considerable potential as
a means of modulating the activity of acyltriazenes. The
acyl group exerts its major influence through its elec-
tronic characteristics, which serve to modulate the rate
and mechanism by which acyltriazenes decompose into
reactive products. In the extreme, the acyl group can
change the fundamental chemistry of the acyltriazenes,
as had been observed in the case of 1-(2-chloroethyl)-3-
(14) Ahmed, M., and Hadi, S. M. (1988) Sequence preference in
alkylation of DNA by N-methyl-N-nitrosourea and N-ethyl-N-
nitrosourea. Med. Sci. Res. 16, 1173-1174.
(15) Hartley, J . A., Gibson. N. W., Kohn, K. W., and Mattes, W. B.
(1986) DNA sequence selectivity of guanine-N-7 alkylation by
three antitumor chloroethylating agents. Cancer Res. 46, 1943-
1947.